Ascendia Pharmaceutical Solutions
ASCENDIA PHARMACEUTICALS, INC.
Ascendia Pharmaceutical Solutions provides novel formulation, analytical and manufacturing services for sophisticated pharmaceutical products. We're a specialty CDMO leader.
ascendiacdmo.com · North Brunswick, NJ
Funding event
The round itself, as filedInferred stageSeed
Sold of offered$4.1M of $4.1M
Filed2026-07-24
Days since filing72
- Exemption claimed
- Rule 506(b)
- First-ever Form D
- No
- Date of first sale
- 2026-06-26
Investors
No investors named: Form D does not list them
Officers on the filing
Names and roles as filed; addresses are never stored- Jingjun HuangDirector
- Michael BogdaDirector
- James GaleDirector
- Robert BloderDirector
- Theron OdlaugDirector
- Shoufeng LiDirector
Health flags
Three flags, each with the raw inputs behind it · as of 2026-10-03UndersubscribedNot flagged100% sold3.3 months since first sale
Prior raiseNot flaggedPrior raise not known—
AmendedNot flaggedNo amendmentNo D/A on file
Open roles
On the employer's own careers page · checked 2026-09-242
Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.
- Formulation ScientistSEP 25Pharmaceutical R&D · open 9 days
- Analytical ScientistSEP 25Pharmaceutical R&D · open 9 days
Also raised in Health & bio
Same sector, 28 days to 2026-10-04Altay TherapeuticsSeries A · $15.7M of $45.1M · San Carlos, CAQuietCarebilitySeries A · $8.8M of $8.8M · Richardson, TXQuiet
75 rounds in Health & bio in the 28 days to 2026-10-03, against 71 in the 28 days before.